AWHAspira Women's Health Inc.

Nasdaq aspirawh.com


$ 0.85 $ -0.09 (-9.43 %)    

Wednesday, 11-Sep-2024 15:59:50 EDT
QQQ $ 470.28 $ 1.65 (0.35 %)
DIA $ 409.10 $ -0.36 (-0.09 %)
SPY $ 555.70 $ 0.71 (0.13 %)
TLT $ 100.09 $ -0.28 (-0.28 %)
GLD $ 234.99 $ 0.35 (0.15 %)
$ 0.831
-- x --
$ 0.90 x 165
-- - --
$ 0.81 - $ 6.59
141,118
na
13.35M
$ 1.17
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-15-2024 03-31-2024 10-Q
3 03-29-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-30-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-10-2022 06-30-2022 10-Q
10 05-11-2022 03-31-2022 10-Q
11 03-31-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-14-2021 03-31-2021 10-Q
15 03-31-2021 12-31-2020 10-K
16 11-12-2020 09-30-2020 10-Q
17 08-14-2020 06-30-2020 10-Q
18 05-14-2020 03-31-2020 10-Q
19 04-07-2020 12-31-2019 10-K
20 11-12-2019 09-30-2019 10-Q
21 08-08-2019 06-30-2019 10-Q
22 05-14-2019 03-31-2019 10-Q
23 03-28-2019 12-31-2018 10-K
24 11-08-2018 09-30-2018 10-Q
25 08-09-2018 06-30-2018 10-Q
26 05-14-2018 03-31-2018 10-Q
27 03-13-2018 12-31-2017 10-K
28 11-08-2017 09-30-2017 10-Q
29 08-11-2017 06-30-2017 10-Q
30 05-11-2017 03-31-2017 10-Q
31 03-31-2017 12-31-2016 10-K
32 11-10-2016 09-30-2016 10-Q
33 08-10-2016 06-30-2016 10-Q
34 05-16-2016 03-31-2016 10-Q
35 03-30-2016 12-31-2015 10-K
36 11-12-2015 09-30-2015 10-Q
37 08-13-2015 06-30-2015 10-Q
38 05-12-2015 03-31-2015 10-Q
39 03-31-2015 12-31-2014 10-K
40 11-13-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 aspira-womens-health-announces-publication-of-data-demonstrating-performance-of-its-in-development-blood-test-for-the-assessment-of-malignancy-risk-in-patients-with-an-adnexal-mass

Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical based women's health company focused on th...

 alliance-global-partners-maintains-buy-on-aspira-womens-health-lowers-price-target-to-55

Alliance Global Partners analyst Ben Haynor maintains Aspira Womens Health (NASDAQ:AWH) with a Buy and lowers the price targ...

 aspira-womens-health-q2-2024-gaap-eps-028-beats-030-estimate-sales-2423m-miss-2600m-estimate

Aspira Womens Health (NASDAQ:AWH) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $...

 aspira-womens-health-inc-files-for-offering-of-up-to-25m-shares-by-the-selling-stockholders

- SEC Filing

 aspira-womens-health-announces-preliminary-ovawatch-volume-during-q2-2024-grew-24-qoq-to-1307-units-preliminary-ovasuite-volume-during-q2-2024-grew-11-qoq-to-6471-units

Preliminary OvaWatch® volume during Q2 2024 grew 24% over the prior quarter to 1,307 units Preliminary OvaSuiteSM volume during...

 aspira-womens-health-reveals-private-placement-equity-financing-of-1935m

The company announced it has entered into a securities purchase agreement dated June 30, 2024 with certain existing accredited ...

 aspira-womens-health-providing-a-downward-revision-of-the-2024-cash-used-in-operations-guidance-during-q2-2024-earnings-call

Monthly OvaSuiteSM product volume grew by more than 26% in May compared to January Reimbursement momentum continued with expand...

 aspira-womens-health-q1-eps-039-misses-034-estimate-sales-215m-miss-241m-estimate

Aspira Womens Health (NASDAQ:AWH) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of...

 aspira-womens-health-announces-publication-of-two-ovawatch-peer-reviewed-manuscripts

Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's hea...

 cantor-fitzgerald-reiterates-neutral-on-aspira-womens-health-maintains-33-price-target

Cantor Fitzgerald analyst Ross Osborn reiterates Aspira Womens Health (NASDAQ:AWH) with a Neutral and maintains $3.3 price t...

 cantor-fitzgerald-maintains-neutral-on-aspira-womens-health-lowers-price-target-to-33

Cantor Fitzgerald analyst Ross Osborn maintains Aspira Womens Health (NASDAQ:AWH) with a Neutral and lowers the price target...

 aspira-womens-health-q4-eps-030-beats-045-estimate-sales-213m-miss-254m-estimate

Aspira Womens Health (NASDAQ:AWH) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $...

 earnings-scheduled-for-march-28-2024

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per ...

 first-lady-jill-biden-unveils-100m-in-federal-funding-to-support-rd---watch-out-for-these-women-health-stocks

Jill Biden announces $100 million in federal funding for women's health research, addressing underfunding and lack of aware...

 aspira-womens-health-announces-late-breaking-poster-presentation-at-the-upcoming-71st-annual-scientific-meeting-for-the-society-for-reproductive-investigation

Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical based women's health company focused on th...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION